A prospective multicentre study to determine the association between sarcopenia and grade 3 toxicity in people with metastatic breast cancer undergoing first line cytotoxic chemotherapy (CANDO-4)

Research interests

• The comprehensive evaluation of the immunometabolic phenotype of tumour microenvironment in breast cancer.
• Investigation of the underlying biology and immunomodulatory effects of anti-PD1 and metformin combination using targeted transcriptomics and multiplex immunohistochemistry in a breast tumour murine model.